At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 14 enrolled
Drug / intervention
Oral Testosterone +1 moredrug
Likely dose
Oral Testosterone 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pharmacokinetics of Modified Slow-Release Oral Testosterone Over 10 Days in Normal Men With Experimental Hypogonadism
In Brief
A Phase 1 clinical trial evaluating Oral Testosterone and Acyline for Healthy. Completed, enrolled 14 participants across 1 site.
Detailed Summary
The purpose of this study is to test how the body absorbs a new form of oral testosterone (T). On Day 1 and Day 9 there are overnight stays in the General Clinical Research Center at the University of Washington to monitor blood testosterone levels over a 24-hour period.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsGlaxoSmithKline
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJul 2010
First PostedJul 2010
Primary CompletionOct 2010
Study CompletionJun 2012
TodayJul 2026
First PostedJul 22, 2010
Enrollment StartJul 1, 2010
Primary CompletionOct 1, 2010
Study CompletionJun 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 15.9 years ago
Interventions
Oral Testosteronedrug
Oral Testosterone: 300 mg, pills, three times daily Day 1 - 10 (total of 27 pills)
Acylinedrug
300 ug/kg injection on Day 0